ANSELL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.74 AUD | -1.20% |
|
-2.21% | -1.75% |
| Apr. 15 | Ansell Launches AU$65 Million Share Purchase Plan | MT |
| Apr. 10 | JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20 | MT |
| Sales 2024 * | 1.63B 2.47B | Sales 2025 * | 1.92B 2.9B | Capitalization | 2.31B 3.5B |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 123M | Net income 2025 * | 157M 238M | EV / Sales 2024 * | 1.58 x |
| Net Debt 2024 * | 265M 401M | Net Debt 2025 * | 457M 692M | EV / Sales 2025 * | 1.44 x |
| P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
14.4
x | Employees | 14,000 |
| Yield 2024 * |
2.33% | Yield 2025 * |
2.8% | Free-Float | 98.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ansell Limited
More recommendations
More press releases
More news
| 1 day | -1.20% | ||
| 1 week | -2.21% | ||
| Current month | -3.32% | ||
| 1 month | +1.14% | ||
| 3 months | +0.65% | ||
| 6 months | +11.69% | ||
| Current year | -1.75% |
1 week
24.70
25.62
1 month
23.8727.49
Current year
22.5127.49
1 year
21.0027.91
3 years
21.0044.07
5 years
20.1944.07
10 years
14.7644.07
| Managers | Title | Age | Since |
|---|---|---|---|
Neil Salmon
CEO | Chief Executive Officer | 55 | 13-07-14 |
Zubair Javeed
DFI | Director of Finance/CFO | - | 19-04-22 |
John Marsden
COO | Chief Operating Officer | - | 19-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ying Yan
BRD | Director/Board Member | 58 | 19-03-31 |
Nigel Garrard
CHM | Chairman | 63 | 20-02-29 |
William Reilly
BRD | Director/Board Member | - | 99-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 1,120 M€ | +1.88% | ||
| 0.02% | 773 M€ | -.--% | - | |
| 0.01% | 7 M€ | +3.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 24.74 | -1.20% | 215,428 |
| 24-05-02 | 25.04 | -0.52% | 190,858 |
| 24-05-01 | 25.17 | -1.64% | 296,404 |
| 24-04-30 | 25.59 | +0.67% | 330,044 |
| 24-04-29 | 25.42 | +0.47% | 398,101 |
Delayed Quote Australian S.E., May 03, 2024 at 02:10 am EDT
More quotes
Ansell Limited is an Australia-based safety solutions and an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. The Company is engaged in designing, developing, and manufacturing a wide range of hand, arm and body protection solutions and clothing. The Company operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. It serves various sectors including automotive, chemical, energy, healthcare, and others.
Calendar
2024-08-19
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.36
USD
Average target price
17.78
USD
Spread / Average Target
+8.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.75% | 2.31B | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.8B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- ANN Stock
